Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Valneva Full Year 2025 Earnings Call - Lyme Phase 3 Readout Imminent, Could Be Transformational
Valneva closed 2025 with steady top line and a sharpened focus on its proprietary vaccines, while waiting for a potentially company changing Phase 3 readout from its Lyme vaccine program run by partne...
- Valneva reported total product sales of EUR 157.9 million for 2025 and said total revenues exceeded EUR 170 million.
- Year-end cash was nearly EUR 110 million and the company completed a debt refinancing, improving financial flexibility.
- Operating loss for 2025 was EUR 82.1 million versus an operating profit of EUR 13.3 million in 2024; net loss was EUR 115.2 million and adjusted EBITDA was -EUR 51.4 million. The 2024 numbers benefited from a one-time sale of a priority review voucher that generated EUR 90.8 million.
- +13 more takeaways
One Stop Systems Q4 2025 Earnings Call - Bressner Sale and Pivot to Pure-Play Rugged AI Edge Compute with 70% Revenue Growth
OSS closed 2025 with a clean strategic pivot and tangible financial progress. Management completed an opportunistic sale of Bressner for roughly $22.4 million, leaving OSS a pure-play provider of rugg...
- Closed sale of Bressner for approximately $22.4 million, proceeds subject to working capital adjustments, Bressner now reported as discontinued operations.
- Q4 2025 revenue $12.0 million, up 70.2% year over year, and above the prior full-year guidance range of $30M to $32M.
- Record quarterly gross margin of 58.5% in Q4 2025, driven by favorable product mix and pricing; company targets sustainable OSS segment margins in mid-30s to mid-40s.
- +12 more takeaways
Tecogen Inc Q4 2025 Earnings Call - Vertiv demo secures proof point and could unlock 25-50 MW of designs
Tecogen spent the quarter building the plumbing for a large pivot into data center cooling, and the most tangible outcome is a Vertiv demonstration unit slated to ship and be tested by the end of Q2. ...
- Vertiv partnership advanced: Vertiv has designed or is designing 25 to 50 megawatts of Tecogen chillers into projects, equivalent to roughly 50 to 100 of Tecogen’s 150-ton dual power source chillers.
- Vertiv demonstration project secured: a 1 MW demo (two 150-ton dual-power chillers) will ship to Vertiv’s controlled environment test chamber and is expected to be running and producing independent data no later than the end of Q2 2025.
- Demonstration is the credibility trigger: management believes the Vertiv test will unlock customer hesitancy and accelerate design-to-order conversion for larger data center projects.
- +12 more takeaways
XOMA Royalty Q4 2025 Earnings Call - Royalties Nearing Inflection Point to Cover Operating Costs
XOMA Royalty spent 2025 building breadth rather than betting big on single winners. The company added 22 assets and two platform technologies, pushed portfolio receipts past $50 million, and grew roya...
- XOMA added 22 portfolio assets in 2025 and acquired two platform technologies, expanding its footprint across preclinical to commercial-stage programs.
- Total portfolio cash receipts exceeded $50 million in 2025, with royalty receipts of approximately $34 million, a 68% increase versus 2024.
- Full-year GAAP income and revenue were $52.1 million in 2025, up from $28.5 million in 2024; cash receipts grew 9% to $50.5 million.
- +13 more takeaways
Ovid Therapeutics Q4 2025 Earnings Call - OV4071 clearance and clean OV329 7 mg data unlock pediatric expansion and extend runway
Ovid reported a dense set of clinical and corporate wins: regulatory clearance in Australia for OV4071, the company’s first oral KCC2 direct activator, and safety/tolerability readout for a 7 mg dose ...
- Regulatory clearance secured in Australia for OV4071, the company’s first oral KCC2 direct activator, triggering a 30-day exercise window for Series A warrants.
- OV4071 Phase 1 is on track to start in Q2 2026, followed by a ketamine challenge later in the year and patient proof-of-concept studies late 2026 or early 2027.
- OV329 7 mg SAD/MAD cohort (n=11 at 7 mg) reported no treatment-related serious adverse events and no treatment-associated adverse events in the cohort tested.
- +12 more takeaways
Jabil Q2 FY2026 Earnings Call - Intelligent Infrastructure and AI lift revenue, prompting higher full-year guide
Jabil beat guidance in Q2, driven by a broad-based surge in Intelligent Infrastructure tied to AI data center builds, and raised its full-year revenue and core EPS outlook. Management flagged a $1.1 b...
- Q2 revenue $8.3 billion, beating guidance and driven by Intelligent Infrastructure and stronger-than-expected regulated industries results.
- Core operating income $436 million and core operating margin 5.3% for Q2; GAAP diluted EPS $2.08, core diluted EPS $2.69.
- Intelligent Infrastructure was the standout, with Q2 revenue of $4.0 billion, up 52% year-over-year, and a 5.7% segment margin, lifted by cloud/DCI, networking, and capital equipment.
- +16 more takeaways
SailPoint Q4 FY2026 Earnings Call - $1.125B ARR, AI-driven non-human identity surge is the next TAM
SailPoint closed FY2026 with clear scale: $1.125 billion ARR, 28% ARR growth and 38% SaaS ARR growth. Management is selling a simple narrative—SaaS momentum plus AI-driven non-human identities will ma...
- SailPoint finished FY2026 with $1.125 billion ARR, up 28% year-over-year, crossing the $1 billion ARR threshold.
- SaaS ARR grew 38% to $746 million and accounted for roughly 90% of net new ARR in Q4, underscoring a clear SaaS-first momentum.
- Management says non-human identities and AI agents are the largest TAM expansion they have seen; non-human identities drove ~25% of SaaS identity growth in Q4 and now represent 11% of SaaS identities under governance.
- +12 more takeaways
Ocean Power Technologies Q3 FY2026 Earnings Call - Backlog Jumps to $19.9M, Pipeline Nears $164M Fueled by Defense Wins
Ocean Power Technologies reported sharp commercial and defense momentum while results still show the friction of scaling a hardware-heavy business. Backlog hit a record $19.9 million and pipeline expa...
- Record backlog reached $19.9 million, up $12.4 million and 165% year-over-year.
- Pipeline expanded to $163.9 million, an 84% year-over-year increase, with larger multi-asset and USV opportunities.
- OPT received a $6.5 million DHS award, and integration with Anduril positions PowerBuoy systems inside a next-generation defense sensing network.
- +13 more takeaways
Spire Global Q4 2025 Earnings Call - RFGL Push Drives 50% 2026 Core Revenue Growth Midpoint
Spire came into 2026 as a smaller, cleaner, and more focused company. After selling its maritime business and retiring all debt, management reported Q4 core revenue momentum, a materially expanded gro...
- Spire reported Q4 revenue of $15.8 million and full year revenue of $71.6 million, with the full-year decline driven by the April 2025 maritime divestiture.
- Excluding the divested maritime business, Q4 revenue grew 44% year over year and 36% sequentially, the metric management uses to run the business.
- For 2026 management guides core revenue of $75 million to $85 million, which at the midpoint implies about 50% year-over-year growth on an ex-maritime basis.
- +12 more takeaways
Macy’s, Inc. Fourth Quarter 2025 Earnings Call - Bold New Chapter Showing Traction, Bloomingdale’s Leads but Tariffs and Lower Asset Gains Temper Optimism
Macy’s reported a quarter that reads like a strategic proof point, not a victory lap. Q4 and full-year 2025 results beat guidance across sales, comps, EBITDA, and adjusted EPS, driven by the Reimagine...
- Q4 2025 net sales were $7.6 billion, above guidance, with total revenue of $7.9 billion, down 1.1% year-over-year primarily due to last year’s store closures.
- Comparable sales (OLM) rose 1.8% in Q4, materially beating guidance, with go-forward comparable sales up about 2% and Macy’s go-forward comps up 0.6% in the quarter.
- Bloomingdale’s was the star, reporting a 9.9% comparable-sales increase in Q4 and 7.4% for fiscal 2025, driven by broad-based strength across categories and channels.
- +12 more takeaways